A study to confirm persistence/recrudescence of trachoma and understand factors facilitating ongoing transmission in six districts of Oromia and SNPP regions of Ethiopia

On this page

Main objectives

This research study is part of a six country portfolio of operational research from the Coalition for Operational Research on NTDs (CORNTD)/International Trachoma Initiative (iTi) on tailored endgame strategies for persistent and recrudescent active trachoma. With leadership from country programs, Sightsavers supported the research studies in Ethiopia, Kenya and Nigeria.

Primary research question:

  • Is there concordance in the TF, infection and serology data (at EU level) in confirming persistence and/or recrudescence of trachoma and the need for on-going interventions?

Secondary research questions:

  • How does TF, anti-Ct antibody and infection data correlate at cluster level and what implications does this have for targeting programmatic interventions?
  • Are there treatment coverage, geographic, demographic, and WASH factors that are correlated with higher pgp3 antibody, Ct infection and/or TF prevalence that could inform more effective program interventions?
  • Are there sociocultural and behavioural factors that are associated with higher TF prevalence that could inform more effective program interventions?
Study details
Start date
1 January 2024
Finish date
30 September 2024
Main contact
Richard Selby
Head of portfolio - NTD research
Partners
  • Fred Hollows Foundation
  • Ministry of Health of Ethiopia
  • Regional Health Bureau, Oromia
  • Regional Health Bureau, SNNP
Funders
Countries